Pfizer is preparing to raise prices for its COVID-19 vaccine, potentially buoying the company’s revenue for years.
FDA Authorizes Pfizer’s Pill to Treat COVID-19
In a potential game-changer in the fight against COVID, the FDA has approved Pfizer’s pill to treat COVID.
Arthritis Drug Approved by the U.S. FDA
The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The twice-daily pill works by blocking molecules known as “Janus kinases.”…
Leukemia Drug Approved by the FDA
Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration. The medication is approved for the treatment of adults with chronic,…